Étiquette : hallucinogenes

Therapeutic Bases of Psychedelic Medicines : Psychointegrative Effects, Michael J. Winkelman, 2007,

Therapeutic Bases of Psychedelic Medicines : Psycho-integrative Effects Michael J. WINKELMAN chapter 1, in "PSYCHEDELIC MEDICINE: SOCIAL, CLINICAL, AND LEGAL PERSPECTIVES" january 2007, pp 1-19.   INTRODUCTION For thousands of years, human beings have used medicinal plants to enhance their health and well-being. In cultures around the world, plants commonly referred to as psychedelic, hallucinogens, and entheogens have played central roles in their healing practices. These vision-inducing plants have also played important roles in the religious and spiritual practices of many societies, evoking powerful emotional, cognitive, and therapeutic reactions. These plants that were central to concepts of health, spirituality, and well-being were, however, demonized and rejected [...]

Lire la suite

Henri Michaux et les gouffres (à propos de l’expérience mescalinienne), François Emmanuel, 2007

Henri Michaux et les gouffres (à propos de l’expérience mescalinienne) François Emmanuel   « Moi n’est jamais que provisoire » (Plume). « J’écris pour me parcourir… » annonçait Henri Michaux. À l’hiver 1954 (il a cinquante-cinq ans) il a amplement parcouru le monde, descendu en pirogue un affluent de l’Amazone, promené son étrangeté en Inde, en Chine, en Malaisie…, ramené de ces pays lointains des notations buissonnières, éparses, décalées, des fables drolatiques. Çà et là il s’est fait entomologiste fantasque ou zoologiste d’animaux fantastiques. Toujours curieux de l’ailleurs mais toujours un peu déçu, il a délaissé ces contrées réelles pour d’autres imaginaires, s’est lancé [...]

Lire la suite

BIBLIOGRAPHIE : Substances psychédéliques : Pharmacologie, Neurophysiologie, Psychologie, Spiritualité…, Dr Christian SUEUR, GRECC, décembre 2019

BIBLIOGRAPHIE : Substances psychédéliques : Pharmacologie, Neurophysiologie, Psychologie,   Dr Christian SUEUR, GRECC, décembre 2019   Cf également : Bibliographie : Thérapies psychédéliques, Bibliographie : Substances psychédéliques, Culture, Spiritualité, Chamanisme Bibliographie : Psilocybine, Bibliographie : LSD, Bibliographie : Ayahuasca….  

Lire la suite

LSD enhances suggestibility in healthy volunteers, R. L. Carhart-Harris et al., 2014

LSD enhances suggestibility in healthy volunteers R. L. Carhart-Harris, M. Kaelen, M. G. Whalley, M. Bolstridge, A. Feilding, D. J. Nutt Psychopharmacology, 2014 DOI 10.1007/s00213-014-3714-z   Abstract Rationale : Lysergic acid diethylamide (LSD) has a history of use as a psychotherapeutic aid in the treatment of mood disorders and addiction, and it was also explored as an enhancer of mind control. Objectives : The present study sought to test the effect of LSD on suggestibility in a modern research study. Methods : Ten healthy volunteers were administered with intravenous (i.v.) LSD (40–80 μg) in a within-subject placebocontrolled design. Suggestibility and cued mental imagery were assessed using the Creative [...]

Lire la suite

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in endstage cancer, Rafael Guimarães dos Santos et al., 2019

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in endstage cancer Rafael Guimarães dos Santos, José Carlos Bouso and Jaime E. C. Hallak BMC Psychiatry, 2019, 19, 321 https://doi.org/10.1186/s12888-019-2288-z   Abstract In a recent issue of the BMC Psychiatry, the evidence of effectiveness of treatments for psychiatric conditions in end-stage cancer patients was reviewed (Johnson, 2018). The review was comprehensive, and included traditional and non-traditional/alternative treatments, including herbal medicines and spirituality. However, evidence showing that classic or serotonergic hallucinogens/psychedelics such as psilocybin and lysergic acid diethylamide (LSD) could be effective treatments for depressive and anxiety disorders in end-stage cancer was not included. In [...]

Lire la suite

Ayahuasca : Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness, Jonathan Hamill et al., 2019

Ayahuasca : Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness Jonathan Hamill, Jaime Hallak, Serdar M. Dursun and Glen Baker Current Neuropharmacology, 2019, 17, 108-128. Doi : 10.2174/1570159X16666180125095902   Abstract Background : Ayahuasca, a traditional Amazonian decoction with psychoactive properties, is made from bark of the Banisteriopsis caapi vine (containing beta-carboline alkaloids) andleaves of the Psychotria viridis bush (supplying the hallucinogen N,N-dimethyltryptamine, DMT). Originally used by indigenous shamans for the purposes of spirit communication, magical experiences, healing, and religious rituals across several South American countries, ayahuasca has been incorporated into folk medicine and spiritual healing, and several Brazilian churches use [...]

Lire la suite

Modulation of Social Cognition via Hallucinogens and “Entactogens”, Katrin H. Preller and Franz X. Vollenweider, 2019

Modulation of Social Cognition via Hallucinogens and “Entactogens” Katrin H. Preller and Franz X. Vollenweider Frontiers in Psychiatry, décembre 2019 doi: 10.3389/fpsyt.2019.00881 Social cognition is a fundamental ability in human everyday lives. Deficits in social functioning also represent a core aspect of many psychiatric disorders. Yet, despite its significance, deficits in social cognition skills are insufficiently targeted by current treatments. Hallucinogens and entactogens have been shown to have the potential to modulate social processing. This article reviews the literature on the influence of hallucinogens and entactogens on social processing in controlled experimental studies in humans and elucidates the underlying neurobiological and neuropharmacological mechanisms. Furthermore, [...]

Lire la suite

Psychedelics and music : neuroscience and therapeutic implications, Frederick S. Barrett et al., 2018

Psychedelics and music : neuroscience and therapeutic implications Frederick S. Barrett, Katrin H. Preller & Mendel Kaelen International Review of Psychiatry, 2018 https://doi.org/10.1080/09540261.2018.1484342   ABSTRACT From the beginning of therapeutic research with psychedelics, music listening has been consistently used as a method to guide or support therapeutic experiences during the acute effects of psychedelic drugs. Recent findings point to the potential of music to support meaning-making, emotionality, and mental imagery after the administration of psychedelics, and suggest that music plays an important role in facilitating positive clinical outcomes of psychedelic therapy. This review explores the history of, contemporary research on, and future directions regarding the use [...]

Lire la suite

Chemistry, pharmacology and medicinal properties of Peganum harmala L., Jinous Asgarpanah and Fereshteh Ramezanloo, 2012

Chemistry, pharmacology and medicinal properties of Peganum harmala L. Jinous Asgarpanah and Fereshteh Ramezanloo African journal of pharmacy and pharmacology, 2012, 6, (22), 1573-1580. Doi : 10.5897/AJPP11.876   Peganum harmala L. is known as Syrian rue, Wild rue and Harmal. P. harmala extracts are considered important for drug development, because they are reported to have numerous pharmacological activities in the Middle East, especially in Iran and Egypt. For a long time P. harmala has been used in traditional medicines for the relief of pain and as an antiseptic agent. P. harmala also have antibacterial, antifungal, antiviral, antioxidant, antidiabetic, antitumor, antileishmanial, insecticidal and cytotoxic activities and hepatoprotective and antinociceptive effects. Harmaline, [...]

Lire la suite

Hallucinogens and Their Therapeutic Use : A Literature Review, Matthew J. BEGOLA, Jason E. SCHILLERSTROM,2019

Hallucinogens and Their Therapeutic Use : A Literature Review Matthew J. BEGOLA, Jason E. SCHILLERSTROM Journal of Psychiatric Practice, 2019, 25, (5), 334–346 Doi : 10.1097/PRA.0000000000000409   The exploration of possible therapeutic benefitsof hallucinogenic substances has undergone a revitalization in the past decade. This literature review investigated the published literature regarding the psychotherapeutic uses of hallucinogens in psychiatric disorders. The results showed that a variety of substances have been evaluated in the treatment of psychiatric disorders, including ayahuasca, ibogaine, ketamine, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, and psilocybin. The conditions treated ranged from depression to autism, with the largest volume of research dedicated to substance use disorders. [...]

Lire la suite